Cornelis J F van Noorden
Overview
Explore the profile of Cornelis J F van Noorden including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
167
Citations
5053
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
van Noorden C, Breznik B, Novak M, van Dijck A, Tanan S, Vittori M, et al.
J Histochem Cytochem
. 2021 Oct;
70(1):29-51.
PMID: 34714696
Energy production by means of ATP synthesis in cancer cells has been investigated frequently as a potential therapeutic target in this century. Both (an)aerobic glycolysis and oxidative phosphorylation (OXPHOS) have...
12.
Khurshed M, Molenaar R, van Linde M, Mathot R, Struys E, van Wezel T, et al.
Cancers (Basel)
. 2021 Jun;
13(10).
PMID: 34069550
Background: Mutations in isocitrate dehydrogenase 1 () occur in 60% of chondrosarcoma, 80% of WHO grade II-IV glioma and 20% of intrahepatic cholangiocarcinoma. These solid -mutated tumors produce the oncometabolite...
13.
Dallinga M, Habani Y, Schimmel A, Dallinga-Thie G, van Noorden C, Klaassen I, et al.
Cells
. 2021 Apr;
10(4).
PMID: 33923753
During angiogenesis, vascular endothelial growth factor A (VEGFA) regulates endothelial cell (EC) survival, tip cell formation, and stalk cell proliferation via VEGF receptor 2 (VEGFR2). VEGFR2 can interact with VEGFR2...
14.
van Noorden C, Hira V, van Dijck A, Novak M, Breznik B, Molenaar R
Cells
. 2021 Apr;
10(3).
PMID: 33810170
Cancer is a redox disease. Low levels of reactive oxygen species (ROS) are beneficial for cells and have anti-cancer effects. ROS are produced in the mitochondria during ATP production by...
15.
Hira V, Molenaar R, Breznik B, Lah T, Aronica E, van Noorden C
J Histochem Cytochem
. 2021 Feb;
69(5):349-364.
PMID: 33596115
Glioblastoma usually recurs after therapy consisting of surgery, radiotherapy, and chemotherapy. Recurrence is at least partly caused by glioblastoma stem cells (GSCs) that are maintained in intratumoral hypoxic peri-arteriolar microenvironments,...
16.
Yetkin-Arik B, Kastelein A, Klaassen I, Jansen C, Latul Y, Vittori M, et al.
Biochim Biophys Acta Rev Cancer
. 2020 Oct;
1875(1):188446.
PMID: 33058997
Angiogenesis is required in cancer, including gynecological cancers, for the growth of primary tumors and secondary metastases. Development of anti-angiogenesis therapy in gynecological cancers and improvement of its efficacy have...
17.
Dallinga M, Habani Y, Kayser R, van Noorden C, Klaassen I, Schlingemann R
Mol Biol Rep
. 2020 Mar;
47(4):2561-2572.
PMID: 32133604
Purpose: We have previously identified insulin-like growth factor 2 (IGF2) and insulin-like growth factor 1 receptor (IGF1R) as essential proteins for tip cell maintenance and sprouting angiogenesis. In this study,...
18.
Jansen C, Kastelein A, Kleinrouweler C, van Leeuwen E, de Jong K, Pajkrt E, et al.
Acta Obstet Gynecol Scand
. 2020 Feb;
99(8):983-993.
PMID: 32108320
Low-lying placentas, placenta previa and abnormally invasive placentas are the most frequently occurring placental abnormalities in location and anatomy. These conditions can have serious consequences for mother and fetus mainly...
19.
Hira V, van Noorden C, Molenaar R
Biology (Basel)
. 2020 Feb;
9(2).
PMID: 32079173
Glioblastoma is the most aggressive and malignant primary brain tumor in adults and has a poor patient survival of only 20 months after diagnosis. This poor patient survival is at...
20.
Thong M, van Noorden C, Steindorf K, Arndt V
Curr Treat Options Oncol
. 2020 Feb;
21(2):17.
PMID: 32025928
Cancer-related fatigue (CRF) is a problem for a significant proportion of cancer survivors during and after active cancer treatment. However, CRF is underdiagnosed and undertreated. Interventions are available for CRF...